Contrary to what we may think, changing people’s default status from non-donor to donor cannot significantly increase organ donation rates — as long as the family is involved in the decision.
The Covid-19 pandemic has laid bare Europe’s vulnerability to drug-supply disruption. Still, it remains by far the world leader in pharmaceutical products.